John W. Childs, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 8,890 shares at $123.30 ($1.1M) on 2021-11-10, disclosed to the SEC on 2021-11-10.
Open-market purchase of $1.1M BHVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.75 | 3,890 | $477K | 43.7% |
| 2 | $122.75 | 3,890 | $477K | 43.7% |
| 3 | $123.30 | 1,110 | $137K | 12.5% |
| Total | $122.82 avg | 8,890 | $1.1M | 100% |
| Filing → |
| MANE | BUY | 2026-02-05 | $5.0M | — | Filing → |
| BHVN | BUY | 2025-11-17 | $50.0M | — | Filing → |
| BHVN | BUY | 2025-03-05 | $892K | — | Filing → |